+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine Testing Product Market, by Product Type, by Technology, by Test Type, by Disease Indication, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • PDF Icon

    Report

  • 208 Pages
  • May 2022
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5601319
Endocrine testing includes diagnosis of endocrine related disorders such as infertility, diabetes, and thyroid related disorders. The diagnosis of various endocrine system disorders are determined by evaluating different endocrine hormone levels in the blood. The global endocrine testing market is expected to witness significant growth, owing to increasing incidence of lifestyle disorders such as hypothyroidism, hyperthyroidism, infertility, and diabetes. For instance, according to American Thyroid Association report 2017, the U.S. performs approximately 15% to 30% thyroid fine needle aspiration (FNA) on an annual basis.



Market Dynamics


Market players are engaged in launching new products for endocrine testing products, this is expected to increase the growth of the global endocrine testing products, over the forecast period. For instance, in July 2018, Ortho Clinical Diagnostics launched VITROS XT 7600 Integrated System, at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, held in U.S. It has applications in cardiology, infectious diseases, and endocrinology.

Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global endocrine testing products market, over the forecast period. For instance, in 2020, Hackensack Meridian Health, an integrated health care network in New Jersey, U.S. and Quest Diagnostics, entered into a partnership, in order to increase the quality and value of diagnostic services provided to patients and their doctors. Under the partnership agreement, Quest Diagnostics will look after all the laboratory operations and also perform reference testing for around 11 Hackensack Meridian Health hospitals under the long-term full laboratory management partnership agreement.

Moreover, in 2016, Sysmex Corporation and Siemens Healthcare Laboratory Diagnostics extended their partnership through the year 2020. Both the companies are indulged in supply, distributorship, and sales and partnership agreement for hemostasis products including analyzers.

Key features of the study:

  • This report provides an in-depth analysis of the global endocrine testing products market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global endocrine testing products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp), Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global endocrine testing products market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing products market

Detailed Segmentation:


Global Endocrine Testing Products Market, By Product Type:

  • Instruments/Analyzers
  • Consumables

Global Endocrine Testing Products Market, By Technology:

  • Liquid Chromatography-Mass Spectrometry
  • Immunoassay
  • Monoclonal and Polyclonal Antibody
  • Electrochemical/Biosensor (Sensor)
  • Clinical Chemistry

Global Endocrine Testing Products Market, By Test Type:

  • Adrenocorticotropic Hormone (ACTH)
  • Calcitonin
  • Calcium
  • Cortisol
  • Catecholamine
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • Estradiol
  • Follicle Stimulating Hormone
  • Growth Hormone
  • Luteinizing Hormone
  • Prolactin
  • Progesterone
  • Testosterone
  • Thyroid Stimulating Hormone
  • Vitamin D
  • Others

Global Endocrine Testing Products Market, By Disease Indication:

  • Adrenal Insufficiency and Addison Disease
  • Bone Disorders
  • Cancer (Tumor)
  • Infertility
  • Renal Diseases
  • Metabolic (Including Diabetes) and Gastrointestinal Disorders
  • Pituitary Disorders
  • Thyroid Disease
  • Others

Global Endocrine Testing Products Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Satellite Laboratories
  • Commercial Labs
  • Home Care Settings
  • Ambulatory Care Centers

Global Endocrine Testing Products Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Hoffmann-La Roche Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Immunodiagnostic Systems
  • Laboratory Corporation of America Holdings (LabCorp)
  • Fujirebio, Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics
  • Sysmex Corporation
  • MP Biomedicals
  • Ortho Clinical Diagnostics
  • Meridian Life Science, Inc.
Frequently Asked Questions about the Global Endocrine Testing Product Market

What is the estimated value of the Global Endocrine Testing Product Market?

The Global Endocrine Testing Product Market was estimated to be valued at $11695.7 Million in 2022.

What is the growth rate of the Global Endocrine Testing Product Market?

The growth rate of the Global Endocrine Testing Product Market is 8.9%, with an estimated value of $23160.1 Million by 2030.

What is the forecasted size of the Global Endocrine Testing Product Market?

The Global Endocrine Testing Product Market is estimated to be worth $23160.1 Million by 2030.

Who are the key companies in the Global Endocrine Testing Product Market?

Key companies in the Global Endocrine Testing Product Market include Hoffmann, La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio, Rad Laboratories, Inc., Siemens Healthineers and DiaSorin S.p.A..

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Technology
  • Market Snippet, By Test Type
  • Market Snippet, By Disease Indication
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. Global Endocrine Testing Products Market - Impact of Coronavirus (Covid-19) Pandemic
  • Impact on Supply Chain
  • Impact on Research and Development
  • Government Initiatives

5. Global Endocrine Testing Products Market, By Product Type, 2017-2030 (US$ Million)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Instruments/Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Endocrine Testing Products Market, By Technology, 2017 - 2030 (US$ Million)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Liquid Chromatography-Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Monoclonal and Polyclonal Antibody
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Electrochemical/Biosensor (Sensor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Clinical Chemistry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Endocrine Testing Products Market, By Test Type, 2017 - 2030 (US$ Million)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Adrenocorticotropic Hormone (ACTH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Calcitonin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Calcium
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Cortisol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Catecholamine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Estradiol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Follicle Stimulating Hormone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Growth Hormone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Luteinizing Hormone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Prolactin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Progesterone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Testosterone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Thyroid Stimulating Hormone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Vitamin D
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Endocrine Testing Products Market, By Disease Indication, 2017 - 2030 (US$ Million)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Adrenal Insufficiency and Addison Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Bone Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Cancer (Tumor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Infertility
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Renal Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Metabolic (Including Diabetes) and Gastrointestinal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Pituitary Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Thyroid Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Endocrine Testing Products Market, By End User, 2017 - 2030 (US$ Million)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
  • Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Satellite Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Commercial Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Ambulatory Care Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

10. Global Endocrine Testing Products Market, By Region, 2017 - 2030 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2030
  • Regional Trends
  • North America
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
11. Competitive Landscape
  • Company Profiles
  • Hoffmann-La Roche Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Abbott Laboratories
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Agilent Technologies
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • BioMerieux S.A.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Bio-Rad Laboratories, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Siemens Healthineers
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Danaher Corporation
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • DiaSorin S.p.A.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Immunodiagnostic Systems
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Laboratory Corporation of America Holdings (LabCorp)
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Fujirebio, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Thermo Fisher Scientific Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Quest Diagnostics
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Sysmex Corporation
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • MP Biomedicals
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Ortho Clinical Diagnostics
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Meridian Life Science, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views
12. Section
  • References
  • Research Methodology
  • About the Publisher and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Immunodiagnostic Systems
  • Laboratory Corporation of America Holdings (LabCorp)
  • Fujirebio, Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics
  • Sysmex Corporation
  • MP Biomedicals
  • Ortho Clinical Diagnostics
  • Meridian Life Science, Inc.